Atlas Trials

Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer

Clinical trial NCT00828984 · COMPLETED

Trial details

NCT number
NCT00828984
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adenomatous PolypColorectal Carcinoma
Start date
2009-10-01
Primary completion
2014-10-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.